In rare cases, some people experience stomach pain, stomach paralysis, and pancreatitis
No, Rybelsus does not cause withdrawal symptoms or physical dependence
In addition, the provider may discuss lifestyle changes, follow-up visits, and monitoring expectations before treatment begins
This review summarizes current evidence from published trials on the mechanisms, efficacy, and safety of approved and investigational medications, and highlights the potential impact of these therapies on the evolving landscape of obesity care
Over years of study, it has demonstrated a strong safety profile, including: No negative impact on glucose metabolism No antibody formation in monitored trials No serious adverse events linked to its use A tolerability profile similar to placebo These findings support its long-term use within medically supervised weight loss programs